EMEA-000093-PIP02-10
Key facts
| Active substance |
Sotrastaurin acetate
|
| Therapeutic area |
Immunology-Rheumatology-Transplantation
|
| Decision number |
P/24/2011
|
| PIP number |
EMEA-000093-PIP02-10
|
| Pharmaceutical form(s) |
|
| Condition(s) / indication(s) |
Prevention of rejection of transplanted kidney
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Novartis Europharm Ltd
|
| Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|